Abstract
Bone disorders are among the most uncommon causes of stroke, but they should be considered as stroke cause in particular clinical scenarios. On the other hand, osteoporosis/osteopenia and increased fracture risk are well documented post stroke complications. The relationship between stroke and bone health is complex. The current facts suggest that these two conditions share same risk factors, but also are risk factors for each other. However, the evidence shows more clear effect of stroke on the bone health, than in the opposite direction. This extensive review is aiming to fill the huge gap of evidence about this topic, and since bone pathology is extremely rare cause of cerebrovascular accident, although a complex connection between these two conditions definitely exists.
Similar content being viewed by others
References
Myint PK, Poole KE, Warburton EA (2007) Hip fractures after stroke and their prevention. QJM. 100:539–545
Taal MW, Cassidy MJ, Pearson D, Green D, Masud T (1999) Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrol Dial Transplant. 14:1917–1921
Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke. 24:940–946
Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and stroke. Stroke. 34:e20–e22
Nordström A, Eriksson M, Stegmayr B, Gustafson Y, Nordström P (2010) Low bone mineral density is an independent risk factor for stroke and death. Cerebrovasc Dis. 29:130–136
Chen YC, Wu JC, Liu L, Huang WC, Cheng H, Chen TJ et al (2013) Hospitalized osteoporotic vertebral fracture increases the risk of stroke: a population-based cohort study. J Bone Miner Res 28:516–523
Szulc P, Samelson EJ, Kiel DP, Delmas PD (2009) Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res 24:2023–2031
Jørgensen L, Engstad T, Jacobsen BK (2001) Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke. 32:47–51
Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporosis Int. 12:259–265
Browner WS, Lui LY (2001) Cummings SR (2001). Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab. 86:631–637
Poole KE, Reeve J, Warburton EA (2002) Falls, fractures, and osteoporosis after stroke: time to think about protection? Stroke. 33(5):1432–1436
Keene GS, Parker MJ, Pryor GA (1994) Mortality and morbidity after hip fractures. BMJ 307:1248–1250
Schubert TA (1980) Fibrocartilaginous infarct in a German Shepherd dog. Vet Med Small Anim Clin. 75(5):839–842
Ryan LM, Cheung HS, McCarty DJ (1981) Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum. 24:1522–1527
Uhthoff HK, Rahn BA (1981) Healing patterns of metaphyseal fractures. Clin Orthop Relat Res 160:295–303
Kon M, de Visser AC (1981) A poly (HEMA) sponge for restoration of articular cartilage defects. Plast Reconstr Surg. 63:288–294
Jeffrey M, Weels GA (1986) Multifocal ischemic encephalomyelopathy associated with fibrocartilaginous emboli in the lamb. Neuropathol Appl Neurobiol. 12(4):415–424
Cook JR (1988) Fibrocartilaginous embolism. Vet Clin North Am Small Anim Pract. 18(3):581–592
Johnson RC, Anderson WI, King JM (1988) Acute pelvic limb paralysis induced by a lumbar fibrocartilaginous embolism in a sow. Cornell Vet. 78(3):231–234
Neer TM (1992) Fibrocartilaginous emboli. Vet Clin North Am Small Anim Pract. 22(4):1017–1026
Toro-Gonzalez G, Havarro-Roman L, Roman GC, Cantillo J, Serrano B, Herrera M, Vergara I (1993) Acute ischemic stroke from fibrocartilaginous embolism to the middle cerebral artery. Stroke. 24(5):738–740
Bots GT, Wattendorff AR, Buruma OJ, Roos RA, Endtz LJ (1981) Acute myelopathy caused by fibrocartilaginous emboli. Neurology. 31(10):1250–1256
Toro G, Roman GC, Navarro-Roman L, Cantillo J, Serrano B, Vergara I (1994) Natural history of spinal cord infarction caused by nucleus pulposus embolism. Spine. 19(3):360–366
Han JJ, Massagli TL, Jaffe KM (2004) Fibrocartilaginous embolism-an uncommon cause of spinal cord infarction: a case report and review of the literature. Arch Phys Med Rehabil. 85(1):153–157
DeFroda SF, Klinge SA (2016) Fat embolism syndrome with cerebral fat embolism associated with long-bone fracture. Am J Orthop (Belle Mead NJ). 45(7):E515–E521
Taviloglu K, Yanar H (2007) Fat embolism syndrome. Surg Today. 37(1):5–8
Kwiatt ME, Seamon MJ (2013) Fat embolism syndrome. Int J Crit Illn Inj Sci. 3(1):64–68
Prentice D, Ahrens T (1994) Pulmonary complications of trauma. Crit Care Nurs Q. 17(2):24–33
Sikary AK, Kumar M, Dhaka S, Subramanian A (2018) A rare fatal complication of Llizarov procedure. J Forensic Sci. 63(6):1895–1898
Kuo K-H, Pan Y-J, Lao Y-J et al (2014) Dynamic MR imaging patterns of cerebral fat embolism: a systemic review with illustrative cases. AJNR Am J Neuroradiol. 35:1052–1057
Yeap P, Kanodia AK, Main G, Yong A (2015) Role of susceptibility-weighted imaging in demonstration of cerebral fat embolism. BMJ Case Rep 2015:bcr2014207581
Bollerslev J (1987) Osteopetrosis. A genetic and epidemiological study. Clin Genet. 31:86–90
Miyamoto RT, House WF, Brackmann DE (1980) Neurotologic manifestations of the osteopetroses. Arch Otolaryngol. 106:210–214
Allen HA, Haney P, Rao KC (1982) Vascular involvement in cranial hyperostosis. AJNR Am J Neuroradiol. 3:193–195
Lerman-Sagie T, Levi Y, Kidron D, Grunebaum M, Nitzan M (1987) Syndrome of osteopetrosis and muscular degeneration associated with cerebro-oculo-facio-skeletal changes. Am J Med Genet. 28:137–142
Wilms G, Casaer P, Alliet P, Demaerel P, Smet M, Baert AL (1990) Cerebrovascular occlusive complications in osteopetrosis major. Neuroradiology. 32:511–513
Farre JM, Declambre B (1989) Functional consequences and complications of Paget’s disease. Rev Prat. 39:1129–1136
Renier JC (1989) What is Paget’s disease? Rev Prat. 39:1104–1108
Fournie A, Fournie B, Lassoued S (1989) Paget’s disease: errors to be avoided. Rev Prat 39:1143–1146
David LR, Wilson JA, Watson NE, Argenta LC (1996) Cerebral perfusion defects secondary to simple craniosynostosis. J Craniofac Surg. 7(3):177–185
Prontera P, Rogaia D, Mencarelli A, Ottaviani V, Sallicandro E, Guercini G, Esposito S, Bersano A, Merla G, Stangoni G (2017) Juvenile Moyamoya and craniosynostosis in a child with deletion 1p32p31: expanding the clinical spectrum of 1p32p31 deletion syndrome and a review of the literature. Int J Mol Sci. 18(9):1998
Turner LM, Steffensen TS, Leroy J, Gilbert-Barness E (2010) Spondyloepiphyseal dysplasia congenita. Fetal Pediatr Pathol. 29(1):57–62
Schimke RN, Horton WA, King CR (1971) Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome. Lancet. 13:1088–1089
Boerkoel CF, Nowaczyk MJ, Blaser SI, Meschino WS, Weksberg R (1998) (1998). Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet. 78(2):118–122
Ehrich JH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J (1995) Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol. 43(2):89–95
Debopam S, Ramakrishnaiah R (2017) Diffuse carotid arteriosclerosis and stroke in a patient with Schimke immuno-osseous dysplasia. Pediatr Neurol. 71:82–83
Babaei AH, Inaloo S, Basiratnia M (2019) Schimke immuno-osseous dysplasia: a case report. Indian J Nephrol. 29(4):291–294
Sparkes RS, Graham CB (1972) Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature. J Med Genet 9:73–85
Massagué J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641
Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralstone S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen N, Van Hul WI (2000) Mutations in the gene encoding the latency-associated peptide of TGFB1 cause Camurati-Engelmann disease. Nat Genet. 26:273–275
Campos-Xavier AB, Saraiva JM, Savarirayan R, Verloes A, Feingold J, Faivre L, Munnich A, Le Merrer M, Cormier-Daire V (2001) Phenotypic variability at the TGF-β1 locus in Camurati-Engelmann disease. Hum Genet. 109:653–658
Cerrato P, Baima C, Bergui M, Grasso M, Lentini A, Azzaro C, Bosco G, Imperiale D, Migone N, Allavena A, Bergamasco B (2005) Juvenile vertebrobasilar ischaemic stroke in a patient with Camurati-Engelmann disease. Cerebrovasc Dis. 20:283–284
Metcalfe JC, Grainger DJ (1995) Transforming growth factor-beta and the protection from cardiovascular injury hypothesis. Biochem Soc Trans. 23:403–406
Chamberlain J (2001) Transforming growth factor-β: a promising target for antistenosis therapy. Cardiovasc Drug Rev. 19:329–344
Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA (1996) The EXT2 multiple exostoses gene defines a family of putative tumor suppressor genes. Nat Genet. 14:25–32
Wicklund CL, Pauli RM, Johnston D, Hecht JT (1995) Natural history study of hereditary multiple exostoses. Am J Med Genet. 55:43–46
Gouicem D, Palcau L, LeHello C, Coffin O, Maiza D, Berger L (2013) Gigantic clavicle osteochondroma with carotid compression as a rare cause of stroke. J Vasc Surg. 57(3):845–847
Ploumis A, Liampas A, Angelidis M, Theodorou A, Xydis V, Gelalis I, Zampakis P, Panagiotopoulos V (2018) Multiple exostoses syndrome and basilar artery aneurysm: a case report. J Vasc Interv Neurol. 10(2):28–32
Schievink WI (2001) Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 344(12):898–906
Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A (2019) Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 54(3):779–796
Katz JM, Segal AZ (2005) Incidence and etiology of cerebro-vascular disease in patients with malignancy. Curr Atheroscler Rep. 7:280–288
Limper AH, Prakash UB, Kokmen E, Callahan MJ (1988) Cardiopulmonary metastatic lesions of osteosarcoma and associated cerebral infarction. Mayo Clin Proc 63(6):592–595
Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N (1998) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy – a Pediatric Oncology Group study. J Clin Oncol. 16(5):1712–1722
Mortazavi SMJ, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH (2010) Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome. J Bone Joint Surg Am. 92:2095–2101
Hart R, Hindman B (1982) Mechanisms of perioperative cerebral infarction. Stroke. 13:766–773
Vlisides P, Mashour GA (2016) Perioperative stroke. Can J Anaesth. 63(2):193–204
Minhas SV, Goyal P, Patel AA (2016) What are the Risk Factors for Cerebrovascular Accidents After Elective Orthopaedic Surgery? Clin Orthop Relat Res. 474(3):611–618
Brooks DC, Schindler JL (2014) Perioperative stroke: risk assessment, prevention and treatment. Curr Treat Options Cardiovasc Med. 16:282
Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, Sage D, Futter M, Saville G, Clark T, MacMahon S (2000) Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 321:1493–1497
Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW (2014) Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care*. J Neurosurg Anesthesiol. 26(4):273–285
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mijajlovic, M.D., Aleksic, V., Stojanovski, N. et al. Relationship between bone disorders and stroke. Neurol Sci 41, 3579–3587 (2020). https://doi.org/10.1007/s10072-020-04748-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04748-0